Jiansheng Shao, Hui Zhang, Xiamei Zhang, Ying Xu, Jianhua Gu, Li Su
{"title":"猪脚趾甲蛋黄膏通过PI3K-Akt通路促进压疮愈合:一项随机对照试验","authors":"Jiansheng Shao, Hui Zhang, Xiamei Zhang, Ying Xu, Jianhua Gu, Li Su","doi":"10.1177/15347346251348798","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To investigate the efficacy and mechanism of pig's toenail egg yolk ointment in treating pressure ulcers. <b>Methods:</b> Eighty patients with Stage III-IV pressure ulcers were randomized into an experimental group (n = 50) receiving pig's toenail egg yolk ointment and a control group (n = 30) receiving conventional dressing. Clinical outcomes included Pressure Ulcer Scale for Healing(PUSH) score, wound healing rate, healing rate, and dressing costs. Additionally, a rat pressure ulcer model was used to assess healing rates, histopathology, and expression of VEGF, TNF-α, IL-1β, PI3 K, p-PI3 K, AKT, and p-AKT. <b>Results:</b> Clinical research: The experimental group showed significantly lower PUSH scores, higher wound healing rates, and reduced dressing costs compared to the control group (<i>P</i> < 0.05). Animal experiments: In rats, the ointment group demonstrated faster wound healing, neovascularization, and reduced inflammatory cell infiltration. ELISA results showed increased VEGF and decreased TNF-α and IL-1β levels. Western blot analysis indicated elevated p-PI3 K and p-AKT expression in the ointment group (<i>P</i> < 0.05). <b>Conclusion:</b> Pig's toenail egg yolk ointment promotes pressure ulcer healing by enhancing angiogenesis and modulating inflammatory factors through activation of the PI3K-Akt pathway.</p>","PeriodicalId":94229,"journal":{"name":"The international journal of lower extremity wounds","volume":" ","pages":"15347346251348798"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pig's Toenail Egg Yolk Ointment Promotes Pressure Ulcer Healing via the PI3K-Akt Pathway: A Randomized Controlled Trial.\",\"authors\":\"Jiansheng Shao, Hui Zhang, Xiamei Zhang, Ying Xu, Jianhua Gu, Li Su\",\"doi\":\"10.1177/15347346251348798\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> To investigate the efficacy and mechanism of pig's toenail egg yolk ointment in treating pressure ulcers. <b>Methods:</b> Eighty patients with Stage III-IV pressure ulcers were randomized into an experimental group (n = 50) receiving pig's toenail egg yolk ointment and a control group (n = 30) receiving conventional dressing. Clinical outcomes included Pressure Ulcer Scale for Healing(PUSH) score, wound healing rate, healing rate, and dressing costs. Additionally, a rat pressure ulcer model was used to assess healing rates, histopathology, and expression of VEGF, TNF-α, IL-1β, PI3 K, p-PI3 K, AKT, and p-AKT. <b>Results:</b> Clinical research: The experimental group showed significantly lower PUSH scores, higher wound healing rates, and reduced dressing costs compared to the control group (<i>P</i> < 0.05). Animal experiments: In rats, the ointment group demonstrated faster wound healing, neovascularization, and reduced inflammatory cell infiltration. ELISA results showed increased VEGF and decreased TNF-α and IL-1β levels. Western blot analysis indicated elevated p-PI3 K and p-AKT expression in the ointment group (<i>P</i> < 0.05). <b>Conclusion:</b> Pig's toenail egg yolk ointment promotes pressure ulcer healing by enhancing angiogenesis and modulating inflammatory factors through activation of the PI3K-Akt pathway.</p>\",\"PeriodicalId\":94229,\"journal\":{\"name\":\"The international journal of lower extremity wounds\",\"volume\":\" \",\"pages\":\"15347346251348798\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The international journal of lower extremity wounds\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/15347346251348798\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The international journal of lower extremity wounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15347346251348798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pig's Toenail Egg Yolk Ointment Promotes Pressure Ulcer Healing via the PI3K-Akt Pathway: A Randomized Controlled Trial.
Objective: To investigate the efficacy and mechanism of pig's toenail egg yolk ointment in treating pressure ulcers. Methods: Eighty patients with Stage III-IV pressure ulcers were randomized into an experimental group (n = 50) receiving pig's toenail egg yolk ointment and a control group (n = 30) receiving conventional dressing. Clinical outcomes included Pressure Ulcer Scale for Healing(PUSH) score, wound healing rate, healing rate, and dressing costs. Additionally, a rat pressure ulcer model was used to assess healing rates, histopathology, and expression of VEGF, TNF-α, IL-1β, PI3 K, p-PI3 K, AKT, and p-AKT. Results: Clinical research: The experimental group showed significantly lower PUSH scores, higher wound healing rates, and reduced dressing costs compared to the control group (P < 0.05). Animal experiments: In rats, the ointment group demonstrated faster wound healing, neovascularization, and reduced inflammatory cell infiltration. ELISA results showed increased VEGF and decreased TNF-α and IL-1β levels. Western blot analysis indicated elevated p-PI3 K and p-AKT expression in the ointment group (P < 0.05). Conclusion: Pig's toenail egg yolk ointment promotes pressure ulcer healing by enhancing angiogenesis and modulating inflammatory factors through activation of the PI3K-Akt pathway.